Abstract
Background
Compressive hematoma after thyroidectomy is a rare complication (1%) but can potentially be severe. The aim of this study was to search for risk factors, in particular the use of anticoagulants or antiplatelet medication, and to see if the delay of hematoma formation would require 1-day surgery performed in a careful manner.
Materials and methods
Retrospective review of 6,830 patients undergoing thyroidectomy in a single institution (1991 to 2006) identified 70 patients with hematomas requiring reoperation. Case controls (210 patients) were matched for age, gender, year of operation, type of thyroid disease, and type of operation. The notion of anticoagulant or antiplatelet medication was particularly studied. The delay of hematoma formation and the cause of bleeding were studied in univariate analysis by a chi-squared test and a Fischer’s test.
Results
In univariate analysis, the formation of hematoma is not related to age, gender, type of thyroid disease, or type of bleeding. The pre or intraoperatory administration of anticoagulant or antiplatelet medication did not influence hematoma formation. Thirty-seven hematomas (53%) presented within 6 h postoperatively, 26 (37%) between 7 and 24 h and seven (10%) beyond 24 h.
Conclusion
Patients undergoing anticoagulant or antiplatelet treatment are not a high-risk population for hematoma formation. Forty-seven percent of the patients presented postoperative hematomas beyond 6 h postoperatively, leading to the conclusion that 1-day surgery is not safe.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mittendorf EA, Mc Henry CR (2004) Complications and sequelae of thyroidectomy and an analysis of surgeon experience and outcome. Surg Technol Int 12:152–157
Shaha AR, Jaffe BM (1994) Practical management of post-thyroidectomy hematoma. J Surg Oncol 57:235–238 doi:10.1002/jso.2930570406
Lacoste L, Gineste D, Karayan J, Montaz N, Lehuede MS, Girault M et al (1993) Airway complications in thyroid surgery. Ann Otol Rhinol Laryngol 102:441–446
Reeve T, Thompson NW (2000) Complications of thyroid surgery: how to avoid them, how to manage them, and observations on their possible effect on the whole patient. World J Surg 24:971–975 doi:10.1007/s002680010156
Bergamaschi R, Becouarn G, Ronceray J, Arnaud JP (1998) Morbidity of thyroid surgery. Am J Surg 176:71–75 doi:10.1016/S0002-9610(98)00099-3
Burkey SH, Van Heerden JA, Thompson GB, Grant CS, Schleck CD, Farley DR (2001) Re-exploration for symptomatic hematomas after cervical exploration. Surgery 130:914–920 doi:10.1067/msy.2001.118384
Inabnet WB, Shifrin A, Ahmed L, Sinha P (2008) Safety of same day discharge in patients undergoing sutureless thyroidectomy: a comparison of local and general anesthesia. Thyroid 18:57–61 doi:10.1089/thy.2007.0148
Lo Gerfo P, Gates R, Gazetas P (1991) Outpatient and short-stay thyroid surgery. Head Neck 13:97–101 doi:10.1002/hed.2880130203
Steckler RM (1996) Outpatient thyroidectomy; a feasibility study. Am J Surg 152:417–419 doi:10.1016/0002-9610(86)90315-6
Mowschenson PM, Hodin RA (1995) Outpatient thyroid and parathyroid surgery: a prospective study of feasibility, safety, and costs. Surgery 118:1051–1054 doi:10.1016/S0039-6060(05)80113-8
Schwartz AE, Clark OH, Ituarte P, Lo Gerfo P (1998) Therapeutic controversy: thyroid surgery—the choice. J Clin Endocrinol Metab 83:1097–1105 doi:10.1210/jc.83.4.1103
Author information
Authors and Affiliations
Corresponding author
Additional information
“Best of Endocrine Surgery in Europe 2008”
Rights and permissions
About this article
Cite this article
Leyre, P., Desurmont, T., Lacoste, L. et al. Does the risk of compressive hematoma after thyroidectomy authorize 1-day surgery?. Langenbecks Arch Surg 393, 733–737 (2008). https://doi.org/10.1007/s00423-008-0362-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-008-0362-y